Sellin v. Rx Plus, Inc.

730 F. Supp. 1289, 1990 U.S. Dist. LEXIS 1952, 1990 WL 17307
CourtDistrict Court, S.D. New York
DecidedFebruary 26, 1990
Docket88 Civ. 3482 (PKL)
StatusPublished
Cited by3 cases

This text of 730 F. Supp. 1289 (Sellin v. Rx Plus, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sellin v. Rx Plus, Inc., 730 F. Supp. 1289, 1990 U.S. Dist. LEXIS 1952, 1990 WL 17307 (S.D.N.Y. 1990).

Opinion

LEISURE, District Judge.

This is a securities fraud action under Section 12 of the Securities Act of 1933, 15 U.S.C. § 771. Defendants Rajan K. Pillai and Pillai, Brick & Roseman have moved for summary judgment on all claims against them in this action.

BACKGROUND

This case arises out of a stock offering by defendant Rx Plus, Inc. (“Rx Plus”), a subsidiary of defendant Medi-Rx America, Inc. (“Medi-Rx”). Medi-Rx is a Delaware corporation in the business of offering prescribed medications and medical equipment by mail order. Rx Plus is a Delaware corporation whose corporate purpose is to establish a chain of retail pharmacies. De *1290 fendants Sidney Karabel, Gary Takata, and Ronald Urvater are all members of the Board of Directors of Medi-Rx and also comprise the Board of Directors of Rx Plus.

In early 1987, Rx Plus provided to plaintiffs, through a confidential private placement memorandum, an opportunity to purchase stock in the company. The stock was allegedly available for sale through the members of the Rx Plus Board of Directors. Plaintiff Alison Sellin bought $60,000 worth of stock, and plaintiff Daniel Kampel purchased $15,000 worth of stock. The private placement memorandum on which these sales were based allegedly failed to meet the disclosure requirements of federal securities laws or the regulations of the Securities and Exchange Commission. In September 1987, Rx Plus admitted that the private placement memorandum might not have met all the requirements of Section 5 of the Securities Act of 1933, 15 U.S.C. § 111. Accordingly, Rx Plus agreed to allow buyers of the stock offered under the possibly offending placement memorandum to rescind their purchases. Both plaintiffs accepted Rx Plus’s offer. However, both allege that they have never received a refund from Rx Plus for the purchase price.

Plaintiffs aver that defendants Rx Plus, Medi-Rx, and the members of the Rx Plus Board intentionally released an insufficient placement memorandum. Plaintiffs claim that the money raised through the stock offering was not intended to fund start up costs of Rx Plus’s retail chain, but was in fact intended to fund the substantial debt incurred by Medi-Rx due to recent operating losses.

The allegedly deficient placement memorandum was drafted by defendant law firm Pillai, Brick & Roseman, of which defendant Rajan K. Pillai (“Pillai”) is a partner. Plaintiffs allege that Pillai and his firm knew or should have known of the insufficient and fraudulent nature of the placement memorandum, and were also aware of Rx Plus’s purposes in releasing such a misleading memorandum. Further, plaintiffs allege that Pillai and his firm may have been directly involved in the marketing of the improperly issued stock.

This action was filed on May 18, 1988. Defendant Pillai and his firm have now moved for summary judgment on all claims against them.

DISCUSSION

Defendants Pillai, Brick & Roseman and Rajan K. Pillai have moved for relief under Fed.R.Civ.P. 56. Rule 56(c) of the Federal Rules of Civil Procedure provides that summary judgment “shall be rendered forthwith if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” “ '[A] motion for summary judgment should be granted only “when, viewing the record in the light most favorable to the non-moving party, the evidence offered demonstrates that there is no genuine issue of fact and that the moving party is entitled to judgment as a matter of law.” ’ ” Leberman v. John Blair & Co., 880 F.2d 1555, 1559 (2d Cir.1989), quoting Pension Benefit Guaranty Corp. v. LTV Corp., 875 F.2d 1008, 1015 (2d Cir.1989), quoting Cinema North Corp. v. Plaza at Latham Associates, 867 F.2d 135, 138 (2d Cir.1989).

The substantive law governing the case will identify those facts which are material, and “[ojnly disputes over facts that might affect the outcome of the suit under the governing law will properly preclude the entry of summary judgment.... While the materiality determination rests on the substantive law, it is the substantive law’s identification of which facts are crucial and which facts are irrelevant that governs.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986). The Court must then determine whether there does indeed exist a genuine issue as to any material fact: “[T]he judge’s function is not himself to weigh the evidence and determine the truth of the matter but to determine whether there is a genuine issue for trial.” Id. at 249, 106 S.Ct. at 2511; see also R.C. Bigelow, Inc. v. *1291 Unilever N. V., 867 F.2d 102 (2d Cir.), cert. denied sub nom. Lipton v. R.C. Bigelow, Inc., — U.S. -, 110 S.Ct. 64, 107 L.Ed.2d 31 (1989). The party seeking summary judgment “always bears the initial responsibility of informing the district court of the basis for its motion, and identifying those portions of ‘the pleadings, depositions, answers to interrogatories, and admissions on file, together with affidavits if any,’ which it believes demonstrates the absence of a genuine issue of material fact.” Celotex Corp. v. Catrett, 477 U.S. 317, 323, 106 S.Ct. 2548, 2552, 91 L.Ed.2d 265 (1986), quoting Fed.R.Civ.P. 56(c). See also Trebor Sportswear Co. v. The Limited Stores, Inc., 865 F.2d 506 (2d Cir.1989). However, Rule 56 does not require that the moving party support its motion with affidavits or other similar materials which negate the opponent’s claim. Rather, “the motion may, and should, be granted so long as what is before the district court demonstrates that the standard for the entry of summary judgment, as set forth in Rule 56(c), is satisfied.” Celotex, supra, 477 U.S. at 323, 106 S.Ct. at 2552. The burden on the moving party will be “discharged by ‘showing’ — that is, pointing out to the District Court — that there is an absence of evidence to support the non-moving party’s case.” Id. at 325, 106 S.Ct. at 2554.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Levitt ex rel. Levitt v. J.P. Morgan Securities Inc.
9 F. Supp. 3d 259 (E.D. New York, 2014)
Monahan v. City of New York Department of Correction
10 F. Supp. 2d 420 (S.D. New York, 1998)
Shain v. Duff & Phelps Credit Rating Co.
915 F. Supp. 575 (S.D. New York, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
730 F. Supp. 1289, 1990 U.S. Dist. LEXIS 1952, 1990 WL 17307, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sellin-v-rx-plus-inc-nysd-1990.